Loss of cell invasiveness through PKC-mediated syndecan-1 downregulation in melanoma cells under anchorage independency

Experimental Dermatology

Volumn 23, Issue 11, 2014, Pages 843-849

  Wang, Chiachen ^a,b   Tseng, Tingting ^a   Jhang, Yaoyun ^a   Tseng, Jenchih ^a   Hsieh, Chiaohui ^a   Wu, Wen guey ^c   Lee, Shaochen ^a  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b CARDINAL TIEN HOSPITAL   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Anchorage independency; Laminin; Melanoma; Protein kinase C; Syndecan

Indexed keywords

GELATINASE A; LAMININ; PROTEIN KINASE C; PROTEIN KINASE C DELTA; SHORT HAIRPIN RNA; SYNDECAN 1; MMP2 PROTEIN, HUMAN; SDC1 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ARTICLE; CELL ANCHORAGE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME RELEASE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SUSPENSION CELL CULTURE; WESTERN BLOTTING; CELL ADHESION; CELL MOTION; GENE EXPRESSION REGULATION; MELANOMA; METABOLISM; METASTASIS; PHENOTYPE; SKIN TUMOR; TUMOR CELL LINE; TUMOR INVASION;

CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LAMININ; MATRIX METALLOPROTEINASE 2; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHENOTYPE; PROTEIN KINASE C-DELTA; RNA, SMALL INTERFERING; SKIN NEOPLASMS; SYNDECAN-1;

EID: 84926124879     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12550     Document Type: Article

References (49)

1. Toren K L, Parlette E C. Semin Cutan Med Surg 2010: 29: 258-263.
2. Ireland A, Millward M, Pearce R et al. Clin Exp Metastasis 2011: 28: 327-336.
3. Chambers A F, Groom A C, MacDonald I C. Nat Rev Cancer 2002: 2: 563-572.
4. Sahai E. Nat Rev Cancer 2007: 7: 737-749.
5. Chiang A C, Massague J. N Engl J Med 2008: 359: 2814-2823.
6. Kim Y N, Koo K H, Sung J Y et al. Int J Cell Biol 2012: 2012: 306879.
7. Okayama H. Cell Signal 2012: 24: 1599-1609.
8. Zhong X, Rescorla F J. Cell Signal 2012: 24: 393-401.
9. Simpson C D, Anyiwe K, Schimmer A D. Cancer Lett 2008: 272: 177-185.
10. Thullberg M, Stromblad S. Cell Cycle 2008: 7: 984-988.
11. Rennebeck G, Martelli M, Kyprianou N. Cancer Res 2005: 65: 11230-11235.
12. Kenific C M, Thorburn A, Debnath J. Curr Opin Cell Biol 2010: 22: 241-245.
13. Steen S, Nemunaitis J, Fisher T et al. Proc (Bayl Univ Med Cent) 2008: 21: 127-132.
14. Garusi E, Rossi S, Perris R. Cell Mol Life Sci 2012: 69: 553-579.
15. Mythreye K, Blobe G C. Cell Signal 2009: 21: 1548-1558.
16. Xian X, Gopal S, Couchman J R. Cell Tissue Res 2010: 339: 31-46.
17. Wang J Y, Ho T, Trojanek J et al. Oncogene 2005: 24: 3748-3758.
18. Al-Ayoubi A, Tarcsafalvi A, Zheng H et al. J Cell Biochem 2008: 105: 875-884.
19. Arndt N X, Tiralongo J, Madge P D et al. J Cell Biochem 2011: 112: 2230-2240.
20. Szatmari T, Mundt F, Heidari-Hamedani G et al. PLoS One 2012: 7: e48091.
21. Chaffer C L, Weinberg R A. Science 2011: 331: 1559-1564.
22. Subramanian A, Tamayo P, Mootha V K et al. Proc Natl Acad Sci U S A 2005: 102: 15545-15550.
23. Salmivirta M, Mali M, Heino J et al. Exp Cell Res 1994: 215: 180-188.
24. Hoffman M P, Nomizu M, Roque E et al. J Biol Chem 1998: 273: 28633-28641.
25. Bachy S, Letourneur F, Rousselle P. J Cell Physiol 2008: 214: 238-249.
26. Conklin M W, Eickhoff J C, Riching K M et al. Am J Pathol 2011: 178: 1221-1232.
27. Vuoriluoto K, Hognas G, Meller P et al. Matrix Biol 2011: 30: 207-217.
28. Liebersbach B F, Sanderson R D. J Biol Chem 1994: 269: 20013-20019.
29. Durbeej M. Cell Tissue Res 2010: 339: 259-268.
30. Brucato S, Villers C. Biochimie 2002: 84: 681-686.
31. Denning M F. Pigment Cell Melanoma Res 2012: 25: 466-476.
32. Alessi D R. FEBS Lett 1997: 402: 121-123.
33. Mori S, Chang J T, Andrechek E R et al. Oncogene 2009: 28: 2796-2805.
34. Vuoriluoto K, Jokinen J, Kallio K et al. Exp Cell Res 2008: 314: 3369-3381.
35. Kato M, Saunders S, Nguyen H et al. Mol Biol Cell 1995: 6: 559-576.
36. Harada K, Masuda S, Hirano M et al. Hum Pathol 2003: 34: 857-863.
37. Chen C L, Ou D L. Hum Pathol 2006: 37: 1279-1285.
38. Hashimoto Y, Skacel M, Adams J C. BMC Cancer 2008: 8: 185.
39. Szatmari T, Dobra K. Front Oncol 2013: 3: 36.
40. Chao H C, Najjaa H, Villareal M O et al. Exp Dermatol 2013: 22: 131-136.
41. Choi H, Kim M, Ahn S I et al. Exp Dermatol 2014: 23: 172-177.
42. Jung H, Chung H, Chang S E et al. Pigment Cell Melanoma Res 2014: 27: 387-397.
43. Chung H, Lee J H, Jeong D et al. J Biol Chem 2012: 287: 19326-19335.
44. Lee J H, Park H, Chung H et al. J Biol Chem 2009: 284: 27167-27175.
45. Lamorte S, Ferrero S, Aschero S et al. Leukemia 2012: 26: 1081-1090.
46. Oh J H, Lee H S, Park S H et al. Int J Gynecol Cancer 2010: 20: 751-756.
47. Ishino K, Fukazawa H, Shikano M et al. Mol Carcinog 2002: 34: 180-186.
48. Mauro L V, Grossoni V C, Urtreger A J et al. Pancreas 2010: 39: e31-e41.
49. Grossoni V C, Falbo K B, Kazanietz M G et al. Mol Carcinog 2007: 46: 381-390.